MyFinsight
Home
Blog
About
Comprehensive (loss) income
-$45,148K
(-1994.59%↓ Y/Y)
Net (loss) income
-$45,019K
(-2042.99%↓ Y/Y)
Total other
comprehensive (gain) income
-$129K
(-295.45%↓ Y/Y)
Income tax recovery
(expense)
-$273K
(-46.77%↓ Y/Y)
(loss) income before
income taxes
-$45,292K
(-2225.39%↓ Y/Y)
Unrealized (gain) income on
available for sale...
-$129K
(-295.45%↓ Y/Y)
Be One Medicines
Ltd.-Drug Supply
$1,664K
(23671.43%↑ Y/Y)
Jazz-Royalty
$1,589K
(188.91%↑ Y/Y)
Drug Supply For
Ongoing Studies-Jazz
$791K
(-57.03%↓ Y/Y)
Jazz-Research Support
Payments And Other...
$291K
(-38.74%↓ Y/Y)
Be One Medicines
Ltd.-Royalty
$210K
(1005.26%↑ Y/Y)
Drug Supply-Jazz
$45K
Loss from operations
-$42,180K
(-6158.16%↓ Y/Y)
Total other (expense)
income, net
-$3,112K
(-210.94%↓ Y/Y)
Research and development
collaborations
$4,590K
(-90.58%↓ Y/Y)
Interest income
$3,287K
(-4.06%↓ Y/Y)
Other income
(expense), net
$196K
(131.56%↑ Y/Y)
Total operating
expenses
$46,770K
(-5.32%↓ Y/Y)
Interest expense related
to sale of future...
$6,595K
Research and development
$27,435K
(-20.36%↓ Y/Y)
General and
administrative
$19,335K
(29.32%↑ Y/Y)
Back
Back
Income Statement
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)
source: myfinsight.com